Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings
CTKB·Reported May 8, 2024·After market close
Cytek Biosciences, Inc. reported Q1 2024 revenue of $44.9M, beat analyst consensus of $43.6M by $1.3M. Diluted EPS came in at $-0.05.
Revenue
$44.9Mbeat by $1.3M
Consensus: $43.6MDiluted EPS
$-0.05met estimate
Consensus: $-0.05
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Cytek Biosciences, Inc.'s Q1 2024 earnings report.
Cytek Biosciences, Inc. (CTKB) reported Q1 2024 earnings on May 8, 2024 after market close.
Cytek Biosciences, Inc. reported revenue of $44.9M and diluted EPS of $-0.05 for Q1 2024.
Revenue beat the consensus estimate of $43.6M by $1.3M. EPS beat the consensus estimate of $-0.05 by $0.00.
You can read the 10-Q periodic report (0001628280-24-021723) directly on SEC EDGAR. The filing index links above go to sec.gov.